Join the discussion.

STAY UP TO DATE ON THE MOST IMPORTANT ISSUES IN GENETICS TODAY.

Back to full list

Upcoming Webinars

Functional modeling: The next frontier in variant interpretation

Functional modeling: The next frontier in variant interpretation
Keith Nykamp, PhD, Invitae; Douglas M. Fowler, PhD, University of Washington School of Medicine; Carlos Araya, PhD, Invitae
April 09, 2020
noon PST - 1 p.m. PST
Register Now

Join us as we discuss the challenges of variants of uncertain significance (VUS) in the clinical setting and demonstrate the role of functional modeling in addressing some of these challenges. This in-depth presentation will provide insight for both those who watched our previous functional modeling webinar as well as anyone new to the subject.

The webinar will help you:
1. Understand how often to expect VUS results and the traditional approaches to VUS resolution
2. Describe the role of functional modeling as an additional evidence type that can assist in variant classification
3. Define different functional approaches and their application to specific variant types

The National Society of Genetic Counselors has approved the live webinar for 0.1 CEUs (one Category 1 contact hour) as part of Invitae’s webinar series. Participants interested in receiving CEUs must provide their NSGC ID at the time of registration. CEU fees will be covered by Invitae. CEUs will be awarded by NSGC in December 2020.


Past Webinars

Integrating functional modeling to enhance clinical variant interpretation

Robert L. Nussbaum, MD, Chief Medical Officer, Invitae; Swaroop Aradhya, PhD, FACMG, Head of Global Medical Affairs, Invitae
April 02, 2020
View Recording

The program, intended for genetic counselors, geneticists, and other healthcare providers (in the Asia-Pacific time zones) interested in variant classification, will help learners:

1. Define the limitations of existing approaches to address variants of uncertain significance in variant interpretation
2. Evaluate the validity and clinical application of robust, quantitative, and scalable functional modeling approaches to variant classification


Invitae Boosted Exome: Providing affordable, transparent, clinically relevant results

Heather McLaughlin, PhD, FACMG, Medical Director, Invitae
April 02, 2020
View Recording

In this webinar (for clinicians in the EMEA time zone), Heather McLaughlin, PhD, FACMG, will provide an in-depth discussion of the Invitae Boosted Exome, including patient selection, ordering tips, coverage performance, and how Invitae's rigorous analysis is informed by the patient's phenotype and genotype.


Invitae Boosted Exome: Providing affordable, transparent, clinically relevant results

Heather McLaughlin, PhD, FACMG, Medical Director, Invitae
March 12, 2020
View Recording

In this webinar, Heather McLaughlin, PhD, FACMG, will provide an in-depth discussion of the Invitae Boosted Exome, including patient selection, ordering tips, coverage performance, and how Invitae's rigorous analysis is informed by the patient's phenotype and genotype.


Integrating functional modeling to enhance clinical variant interpretation

Robert L. Nussbaum, MD (Invitae Chief Medical Officer) and Swaroop Aradhya, PhD, FACMG (Invitae Head of Global Medical Affairs)
March 03, 2020
View Recording

The webinar, intended for genetic counselors, geneticists, and other healthcare providers interested in variant classification, will help you understand how to:

* define the limitations of existing approaches to variant interpretation

* understand how to address variants of uncertain significance

* evaluate the validity and clinical application of robust, quantitative, and scalable functional modeling approaches to variant classification

Case examples will be provided. Participate in the Q&A session at the end of the webinar by asking questions during the webinar or submitting them in advance at the time of registration.


Diagnostic yield and precision medicine implications from genetic testing in epilepsy

Swaroop Aradhya, PhD, FACMG, Medical Director, Invitae; Molly Stetler, MS, CGC, Clinical Science Liaison, Invitae
January 28, 2020
View Recording

In this webinar, the speakers will examine the results of a large genetic epilepsy study conducted using the Invitae Epilepsy Panel to test more than 9,700 individuals. They will reinforce the need for early detection with genetic testing, discuss the potential precision medicine implications for patients, and highlight the benefits of our sponsored testing program for pediatric epilepsy.